Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement activation in human prion disease.

Gabor G Kovacs1, Philippe Gasque, Thomas Ströbel

  • 1Institute of Neurology, University of Vienna, Vienna, Austria.

Neurobiology of Disease
|January 31, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deciphering Freezing of Gait: What Neuropathology Reveals About an Episodic Phenomenon.

The European journal of neuroscience·2026
Same author

Cognitive, Motor and Oculomotor Contributions to the Trail Making Test in Progressive Supranuclear Palsy.

Movement disorders clinical practice·2026
Same author

A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonism.

Nature medicine·2026
Same author

Distinct neuroinflammatory profiles in progressive supranuclear palsy associated with <i>HLA</i> haplotypes.

Brain communications·2026
Same author

The prevalence of Lewy body pathology across nine international community-based cohorts.

Brain : a journal of neurology·2026
Same author

A repeat expansion in GOLGA8A is a major risk factor for atypical frontotemporal lobar degeneration with ubiquitin-positive inclusions.

Nature genetics·2026
Same journal

Disruption of the claustrum-ACC pathway contributes to human mind blanking.

Neurobiology of disease·2026
Same journal

Loss of immunological control at CD28 superfamily checkpoints links brain and peripheral immunity to depressive-like behaviors in animal models.

Neurobiology of disease·2026
Same journal

Investigating tau-related white matter degeneration in Alzheimer's disease using fixel-based analysis.

Neurobiology of disease·2026
Same journal

Evidence for hippocampal globotriaosylceramide (Gb3) accumulation and spatial memory impairment in a mouse model of Fabry disease.

Neurobiology of disease·2026
Same journal

Leveraging the dominant-negative effect of the kuru-protective G127V prion protein variant as a novel therapeutic strategy.

Neurobiology of disease·2026
Same journal

GDAP1 orchestrates redox signaling at membrane contact sites to preserve axonal integrity in Charcot-Marie-Tooth disease.

Neurobiology of disease·2026
See all related articles

The innate immune system

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Prion diseases (PrD) are characterized by abnormal prion protein accumulation and neuronal loss.
  • A significant immune response is typically absent in prion diseases, despite their infectious nature.
  • Emerging evidence suggests complement system involvement in early prion disease pathogenesis.

Purpose of the Study:

  • To investigate the presence and role of complement system components in human prion disease brains.
  • To correlate complement activation with disease severity and neuronal damage.

Main Methods:

  • Immunohistochemical analysis of human prion disease brain tissue.
  • Detection of complement factors (C1q, C3b) and the membrane attack complex (MAC).
  • Correlation with neuropathological markers of disease severity and neuronal apoptosis (TUNEL labeling).

Related Experiment Videos

Main Results:

  • Active complement components (C1q, C3b) were found in extracellular prion protein deposits.
  • The membrane attack complex (MAC) was identified within neurons.
  • Neuronal MAC localization strongly correlated with disease severity and neuronal apoptosis, independent of prion disease subtype.

Conclusions:

  • The complement system, specifically MAC, is actively involved in the neuropathology of human prion diseases.
  • Complement activation contributes to neuronal damage and correlates with disease progression.
  • These findings highlight the complement system as a potential therapeutic target in prion diseases.